InsidersTradesSigma
Follow the AMPLIA THERAPEUTICS LIMITED share price and the full insider trade history of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the oversight of ASX. Market capitalisation: €71.9m. Every trade is accessible without an account.
Analysts rate AMPLIA THERAPEUTICS LIMITED Strong Buy (bullish), based on 1 analysts. Average price target: A$0.42.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
AMPLIA THERAPEUTICS LIMITED is a company listed on the XASX, focused on developing treatments for cancer and other serious diseases. It emphasizes innovation in the field of targeted therapies.